İçeriğe geç
akaturk Akademik ölçüm
  1. Ana Dal Sağlık Bilimleri Temel Alanı
  2. Yan Dal Klinik Eczacılık
Makale 20 YÖKSİS 20 · OpenAlex 0 Toplam atıf 215 h-indeks 9 · OpenAlex Q1 makale 11 Scopus · WoS Q1 4 En iyi alan sırası #14 / 78 Yan dal · üst %17,9

Atıf etkisi

OpenAlex YÖKSİS makalelerinden OpenAlex’te eşleşen: 15 + YÖKSİS · ortak yazar kaydı: 1
h-indeks 9 Türkiye yüzdelik dilimi: 81 Üniversitesinde h-indekse göre 108. / 1.174
i10-indeks
9
Toplam atıf
215
Türkiye’de üst %24
Makale başına
13,4
FWCI
1,05
1,00 = dünya ortalaması
Dünyada üst %1
0
Dünyada üst %10
2
Nasıl hesaplanır?

h-indeks ve atıflar, bu akademisyenin YÖKSİS makalelerinden OpenAlex’te eşleşenlerin atıf sayılarından hesaplanır (Google Scholar, WoS veya Scopus değildir). Eşleşmeyen makalelerin atıfı dahil değildir. Ortak yazarların YÖKSİS kayıtlarında bu akademisyenin YÖK kimliğiyle etiketlenen 1 makale (0 atıf) yalnızca atıf, h-indeks ve i10 hesabına katılır; makale sayıları, yüzdelik dilimler ve sıralamalar kendi YÖKSİS listesinden hesaplanır.

Alan sıralaması

YÖKSİS ?

Dizinler ve atıf yüzdelikleri

?
TR Index 1 makale
OpenAlex atıf yüzdelik
Üst %10
Üst %102
Ort. · n 13 %68,1
Diğer sayımlar

Scopus (SJR)

  • Özet hariç 13 Q1 8 Q2 2 Q3 1 Q4 2
  • YÖKSİS satırı 16

WoS (JCR)

  • Özet hariç 9 Q1 2 Q2 6 Q4 1
  • YÖKSİS satırı 12

Makaleler

YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.

20makale

Yayını olan dergiler

18 dergi

Daralt

Scopus (SJR)
WoS (JCR)
Q14 Q27 Q30 Q41
TR Index

Makale listesi

  1. 2023 Insulin resistance in Alzheimer’s Disease: The genetics and metabolomics links Clinica Chimica Acta Journal DOI 10.1016/j.cca.2022.12.016 YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %10 OpenAlex 93.9%
  2. 2021 Metabolomics applications in coronary artery disease personalized medicine Advances in clinical chemistry DOI 10.1016/bs.acc.2020.08.003 YÖKSİS SJR Q1 JCR Q1 OpenAlex 87.6%
  3. 2021 The metabolic signatures of cardiometabolic diseases: does the shared metabotype offer new therapeutic targets? Lifestyle Medicine Journal DOI 10.1002/lim2.25 YÖKSİS SJR Q3 OpenAlex 77.1%
  4. 2019 Metabolomics profiling and pathway analysis of human plasma and urine reveal further insights into the multifactorial nature of coronary artery disease Clinica Chimica Acta Journal DOI https://www.sciencedirect.com/science/article/pii/S0009898119300920 YÖKSİS SJR Q1 JCR Q2
  5. 2018 Pharmacometabolomics analysis of plasma to phenotype clopidogrel high on treatment platelets reactivity in coronary artery disease patients European Journal of Pharmaceutical Sciences DOI 10.1016/j.ejps.2018.03.011 YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %10 OpenAlex 91.7%
  6. 2017 The personalization of clopidogrel antiplatelet therapy: the role of integrative pharmacogenetics and pharmacometabolomics Cardiology Research and Practice YÖKSİS SJR Q1 JCR Q4
  7. 2017 TCT-841 Integrative Pharmacometabonomics-Pharmacogenetics approach to predict clopidogrel response in Coronary Artery Disease (CAD) patients undergoing Interventional Angiographic Procedure (IAP) Journal of the American College of Cardiology DOI 10.1016/j.jacc.2017.09.1049 YÖKSİS SJR Q1 JCR Q1
  8. 2017 The effect of CYP2C19 genetic polymorphism and non-genetic factors on clopidogrel platelets inhibition in East Asian coronary artery disease patients Thrombosis Research DOI 10.1016/j.thromres.2017.07.032 YÖKSİS SJR Q2 JCR Q2 OpenAlex 84.1%
  9. 2017 1H NMR based pharmacometabolomics analysis of urine identifies metabolic phenotype of clopidogrel high on treatment platelets reactivity in coronary artery disease patients Journal of Pharmaceutical and Biomedical Analysis DOI 10.1016/j.jpba.2017.08.018 YÖKSİS SJR Q1 JCR Q2 OpenAlex 80.6%
  10. 2017 Plasma metabolic biomarkers for discriminating individuals with alcohol use disorders from social drinkers and alcohol-naive subjects JOURNAL OF SUBSTANCE ABUSE TREATMENT DOI 10.1016/j.jsat.2017.02.015 YÖKSİS SJR Q1 JCR Q2 OpenAlex 67.5%
  11. 2017 Nuclear magnetic resonance spectroscopy based metabolomics to identify novel biomarkers of alcohol-dependence Songklanakarin Journal of Science and Technology DOI 10.14456/sjst-psu.2017.18 YÖKSİS SJR Q2 OpenAlex 54.8%
  12. 2016 PS172 The Effect of Haematological Variables on the Verifynow P2Y12 Assay in Coronary Artery Disease Patients (CAD) Undergoing Interventional Angiographic Procedure Global Heart DOI 10.1016/j.gheart.2016.03.146 YÖKSİS SJR Q1 JCR Q2
  13. 2016 ASTHMA AND METABOLIC SYNDROME-WHERE IS THE LINK? Journal of Faculty of Pharmacy and Science, Universitas Muhammadiyah Prof. DR. HAMKA YÖKSİS
  14. 2016 Metabolic phenotyping of urine for discriminating alcohol-dependent from social drinkers and alcohol-naive subjects DRUG AND ALCOHOL DEPENDENCE DOI 10.1016/j.drugalcdep.2016.10.016 YÖKSİS SJR Q1 JCR Q1 OpenAlex 77.6%
  15. 2016 TCTAP A-126 The Identification of Novel Biomarkers of Clopidogrel High on Treatment Platelets Reactivity Using Pharmacometabonomics Analysis of Plasma in Coronary Artery Disease Patients Journal of the American College of Cardiology DOI 10.1016/j.jacc.2016.03.156 YÖKSİS SJR Q1 JCR Q1 OpenAlex 5.9%
  16. 2015 Novel Biomarkers of Alcohol-Dependence in Urine using Metabolomics Malaysian Journal of Pharmaceutical Sciences YÖKSİS
  17. 2015 The role of Granulocyte Colony-Stimulating Factor and carbapenem therapy in severe melioidosis: A case report from Malaysia Eastern Journal of Medicine YÖKSİS TR Index SJR Q4
  18. 2014 Public Knowledge and Awareness of Cardiovascular Diseases and the Expected Role of Community Pharmacists in the Prevention and Management of Cardiovascular Diseases in Penang Chiang Mai University Journal of Natural Sciences DOI 10.12982/cmujns.2014.0041 YÖKSİS SJR Q4 OpenAlex 66.3%
  19. 2014 Factors associated with the general public knowledge and awareness of cardiovascular diseases and its risk factors in Penang–Malaysia IOSR Journal Of Pharmacy DOI 10.9790/3013-040601021027 YÖKSİS OpenAlex 80.5%
  20. 2014 Acyclovir Induced Acute Kidney Injury In Acute Meningitis Patient: A Case Report Highlights the Concurrence Of AKI Risk Factors And The Neutropenic Effect Of Ticlopidine IOSR Journal of Pharmacy (IOSRPHR) DOI 10.9790/3013-04010058062 YÖKSİS OpenAlex 17.5%

← Akademisyenlere dön